Gamida Cell Ltd. (NASDAQ: GMDA) stock closed at 0.81 per share at the end of the most recent trading day (a 5.19% change compared to the prior day closing price) with a volume of 1.35M shares and market capitalization of 60.41M. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Biotechnology industry, Healthcare sector and employs 83 people. Gamida Cell Ltd. CEO is Julian Adams.

The one-year performance of Gamida Cell Ltd. stock is -81.45%, while year-to-date (YTD) performance is -37.21%. GMDA stock has a five-year performance of %. Its 52-week range is between 0.56 and 4.72, which gives GMDA stock a 52-week price range ratio of 6.01%

Gamida Cell Ltd. currently has a PE ratio of -1.00, a price-to-book (PB) ratio of 7.73, a price-to-sale (PS) ratio of -, a price to cashflow ratio of -, a PEG ratio of 2.32, a ROA of -57.58%, a ROC of -74.63% and a ROE of -270.36%. The company’s profit margin is -%, its EBITDA margin is -%, and its revenue ttm is $0.00 , which makes it $0.00 revenue per share.

Of the last four earnings reports from Gamida Cell Ltd., there were 1 positive earnings surprise and 1 negative earnings surprise. The company has EPS estimate of $-0.27 for the next earnings report. Gamida Cell Ltd.’s next earnings report date is 09th May 2023.

The consensus rating of Wall Street analysts for Gamida Cell Ltd. is Strong Buy (1.2), with a target price of $11.75, which is +1 350.62% compared to the current price. The earnings rating for Gamida Cell Ltd. stock is Sell (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Gamida Cell Ltd. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

Gamida Cell Ltd. has a Sell technical analysis rating based on Technical Indicators (ADX : 13.90, ATR14 : 0.16, CCI20 : -130.79, Chaikin Money Flow : -0.27, MACD : -0.20, Money Flow Index : 20.59, ROC : -47.06, RSI : 30.60, STOCH (14,3) : 21.83, STOCH RSI : 0.37, UO : 37.81, Williams %R : -78.17), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Gamida Cell Ltd. in the last 12-months were: Abigail L. Jenkins (Buy at a value of $25 000), Robert I. Blum (Buy at a value of $77 500), Shawn Cline Tomasello (Buy at a value of $14 999), Stephen Thomas Wills (Buy at a value of $14 999)